If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Get Updates
9
Followers on Owler
Stoke Therapeutics
focuses on developing antisense oligonucleotide medicines for the treatment of genetic diseases...
Read more
Overview
Competitors
Funding
News & Insights
Stoke Therapeutics
focuses on developing antisense oligonucleotide medicines for the treatment of genetic diseases...
Read more
CEO
Ian F. Smith
CEO Approval Rating
90/100
Weigh In
2014
Bedford
Massachusetts
Greater Boston
Public
NASDAQ
STOK
Pharmaceuticals & Biotechnology
Biotechnology
2836
NAICS listing
http://stoketherapeutics.com/
Annual Revenue
$32.1M
Employees
100
Funding
$272M
News
Key Events
Latest News
Leadership Change
Mar 18, 2025
Business Wire
Ian F. Smith joined Stoke Therapeutics as Interim-CEO
Follow and Get Alerts
Stoke Therapeutics Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 24 + competitors
Trending Companies
